From: 26/04/2017 to: 30/04/2017 3rd ESO-ESMO Latin-American Masterclass in Clinical Oncology, San Jose, Costa Rica                                        From: 7/05/2017 to: 7/05/2017 4th ESO Lung Cancer Observatory, Geneva, Switzerland                                        From: 18/05/2017 to: 19/05/2017 Eurasia Course on Gastrointestinal Malignancies, Moscow, Russian Federation                                        From: 22/05/2017 to: 26/05/2017 3rd ESOP-ESO Advanced Masterclass in Oncology Pharmacy, Lisbon, Portugal                                        From: 26/05/2017 to: 27/05/2017 ESMO Preceptorship on Immuno-Oncology 2017, Amsterdam, The Netherlands                                        From: 10/06/2017 to: 13/06/2017 Leukaemia and Lymphoma, Ascona, Switzerland                                        From: 21/06/2017 to: 23/06/2017 Masterclass in Oncology Basics for Beginners, Cambridge, United Kingdom                                        From: 30/06/2017 to: 05/07/2017 4th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Belgrade, Serbia                                        From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 15/07/2017 to: 15/07/2017 Breast Cancer in Young Women: Joint DFCI-ESO Symposium, Boston, US                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 1st Mediterranean Masterclass in Clinical Oncology, Limassol, Cyprus

 THE ROYAL MARSDEN - NHS FOUNDATION TRUST                                                                                London, United Kingdom


Person responsible for CTC programme: Dr Susana Banerjee


Hospital overview:

The Royal Marsden Hospital is a world-leading cancer centre specialising in diagnosis, treatment, care, education and research. Together with its academic partner, The Institute of Cancer Research (ICR), it comprises one of the largest comprehensive cancer centres in Europe, employing over 3,000 scientific, clinical and nursing staff. The joint institution demonstrates the breadth and depth in basic biomedical, translational and clinical research, and provides a highly active clinical research environment where the majority of senior clinicians are engaged in leading or supporting research projects and clinical trials. The Royal Marsden Hospital provides inpatient, day care and outpatient services for cancer patients. There are over 500 clinical research projects active at any one time and high patient recruitment rates to clinical trials.

The Royal Marsden Hospital offers training to medical oncologists, clinical oncologists and surgical oncologists. A fellowship at the Royal Marsden Hospital offers valuable education from leaders in the field, providing fellows with opportunities to develop clinical and research skills to become future leaders in oncology.


CTC programmes offered:

1. Gynaecological Cancers programme
 
Discipline:Medical Oncology

Programme mentor:

Susana Banerjee


Duration:3 - 6 months

Type:Visiting Residency

Language requirements:
Fluent in English


Programme description:
The Gynaecology Unit at the Royal Marsden serves a population of 1.7 million and is also a tertiary referral centre for more complex cases or second opinions. Our Unit treats ovarian (including germ cell), endometrial, cervical, vaginal and vulval cancers.  Management of these tumour types requires a multidisciplinary team approach, and the Gynaecology Unit's clinical research programme reflects this. Dr Susana Banerjee, consultant medical oncologist, is Research L ead. The Unit works in partnership with the Institute of Cancer Research. The number of women undergoing treatment within the Unit, together with the clinical and laboratory research infrastructure has led to significant, pioneering work in gynaecological cancers impacting on patient management.. Our interests include BRCA-associated ovarian cancers, PARP inhibitors, anti-angiogenic agents and the PI3K pathway. We have close collaborations with colleagues (Prof de Bono, Dr Udai Banerji and Prof Stan Kaye) in the Drug Development Unit at Royal Marsden Sutton, so that there is a seamless transition of developing drugs in gynaecological cancers from Phase I trials.

Our clinical trials portfolio focuses on scientifically-driven trials and includes phase I/II to phase III trials. The Medical Gynaecological Oncology Team comprises clinical trials co-ordinators, data managers, research nurses and clinical fellows at the London and Surrey sites.

A 3-6 month clinical fellowship is an exciting opportunity to gain clinical experience in the management of gynaecological cancers in a world-leading centre. The Unit supports research interests of individual fellows and opportunities to be involved in translational research and clinical trials. Fellows will be based across the Royal Marsden Chelsea (London) and Sutton (Surrey) sites.
  
  
2. Sarcoma programme
 
Discipline: Medical Oncology, Radiation

Programme mentor:Charlotte Benson


Duration:3 - 6 months

Type:Visiting Residency and Visiting Observership

Language requirements:Fluent in English


Programme description:The sarcoma oncology unit based at The Royal Marsden Hospital registers more than 850 patients a year, many of whom come for primary disease management or for second opinions regarding further therapy. This combination of patient numbers and research infrastructure makes it ideally placed to make a major contribution to sarcoma research nationally and internationally.

More than 20 years ago the Sarcoma Unit established a comprehensive, prospectively maintained clinical database and now has data on 10,000 patients, providing a hugely valuable resource. This has generated a steady flow of research papers, providing valuable information on the behaviour of individual diseases and hypothesis generating ideas for future, disease-orientated clinical trials.

The Sarcoma Unit maintains a portfolio of clinical trials that encompass the major sarcoma subtypes, supporting the studies being conducted by the National Cancer Research Institute (NCRI), Sarcoma Clinical Studies Group, the EORTC Soft Tissue and Bone Sarcoma Group, working with Pharma on industry- sponsored trials and conducting its own, investigator-initiated studies. The clinical trials team comprises a Clinical Trials Coordinator, a Data Manager / Trials Coordinator, 2 research nurses and a Clinical Research Fellow, supported from local research funds or visiting fellowships.

The Head of the Unit is Dr Robin Jones.

There are four out-patient clinics in the week, one of which is multidisciplinary with surgical, medical oncology and radiation oncology patients seen on the same afternoon.

The importance of multidisciplinary management in sarcoma is reflected by the heavy support from several various oncology teams to provide a complete and complex specialist care for our sarcoma patients. Multidisciplinary Team (MDT) Meetings are held twice weekly, during which diagnosis and treatment of new patients is discussed, post-operative care is determined and the management of complex cases is discussed. A meeting to discuss thoracic surgical patients is held each week. Surgery for sarcoma is undertaken by dedicated surgical oncologists. For cases requiring reconstruction there is an extensive plastic and reconstructive surgical team available for collaborative surgical working. In addition, the MDT extended team includes dedicated representation from other site specific teams such as head and neck and gynaecology for joint surgical managements of sarcomas. The MDT additionally serves as a platform for discussion and treatment planning in patients who require specialist input from interventional radiology, thoracic surgery, palliative care, pharmacy, physiotherapy and rehabilitation.

All Fellows will have the opportunity to contribute to the research portfolio with their individual projects, leading to published abstracts and papers and will have an active role in the management of patients treated within clinical trials.

Fellows will be based across the Royal Marsden Chelsea (London).
  
  
3. Paediatric Oncology programme
  
Discipline:Paediatric Oncology

Programme mentor:

Dr Sucheta Vaidya
Duration:3 - 6 months

Type:Visiting Residency and Visiting Observership

Language requirements:

Fluent in English
Programme description:

Children and young People’s unit at the Royal Marsden Hospital is a modern unit , in the setting of a specialist cancer hospital, comprising of a 18 bed paediatric in-patient ward, 13 bed teenage and young adults (TYA) ward (9 beds open at present). In addition there is a day unit and out patients department, serving the south east of England including South London. The unit is one of the 2 joint Primary Treatment Centres (PTC) in London and patients are referred from 5 cancer networks. The department works in close partnership with St. George’s hospital and has strong academic links with the Institute of Cancer Research.


Approximately 250 new patients are referred every year and the department has an active haematopoietic stem cell transplant and neurooncology  programme. The department has a strong drug development focus and is the lead for several early and late phase trials within UK and Europe.

A 3-6 month clinical fellowship is an exciting opportunity to gain clinical experience in the management of paediatric and adolescent oncology in a world-leading centre.  The candidate will have opportunities to learn from the busy clinical practice and strong research focus.


Fellows will be based across the Royal Marsden hospital at Sutton (Surrey) site.

Head of Department: Dr Julia Chisholm